title: Real-world variability in dabigatran levels in patients with atrial fibrillation: comment.
authors.affiliation: Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Douxfils
authors.affiliation: Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU DinantGodinne UcL Namur, Université Catholique de Louvain, Yvoir, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Chatelain
authors.affiliation: Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
authors.forename: J-M
authors.initials: JM
authors.lastname: Dogné
authors.affiliation: Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU DinantGodinne UcL Namur, Université Catholique de Louvain, Yvoir, Belgium.
authors.forename: F
authors.initials: F
authors.lastname: Mullier
mesh_terms: D000991:Antithrombins / Q000097:blood*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000991:Antithrombins; D000069604:Dabigatran